Olema Pharmaceuticals Inc Stock
Olema Pharmaceuticals Inc Stock price
Key metrics
| Market capitalization | $510.52m |
| Enterprise Value | $297.46m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 2.57 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-135.91m |
| Free Cash Flow (TTM) Free Cash Flow | $-96.70m |
| Cash position | $214.76m |
Is Olema Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Olema Pharmaceuticals Inc Stock Analysis
Analyst Opinions
8 Analysts have issued a Olema Pharmaceuticals Inc forecast:
Analyst Opinions
8 Analysts have issued a Olema Pharmaceuticals Inc forecast:
Financial data from Olema Pharmaceuticals Inc
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.37 -0.37 |
73%
73%
|
|
| EBITDA | -136 -136 |
35%
35%
|
EBIT (Operating Income) EBIT | -136 -136 |
34%
34%
|
| Net Profit | -123 -123 |
28%
28%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Olema Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Olema Pharmaceuticals Inc Stock News
Company Profile
Olema Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of targeted therapies for women's cancers. The company also focuses on OP-1250, a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD) that is being studied in a Phase 1/2 clinical trial for the treatment of metastatic or locally advanced ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema Pharmaceuticals was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
| Head office | United States |
| CEO | Sean Bohen |
| Employees | 74 |
| Founded | 2006 |
| Website | www.olema.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
